Active Ingredient:

Clopidogril bisulfate 97.875 mg equivalent to 75 mg of clopidogril base


Blotagril (clopidogril bisulfate) is indicated for the reduction of atherothrombotic events as follows:

  • Recent MI, Recent Stroke or established peripheral arterial disease.patients with a history of recent myocardial infarction (MI), recent stroke, or established peripheral arterial disease, blotagril has been shown to reduce the rate of combined endpoint of new ischemic stroke (fatal or not), new MI (fatal or not), vascular death.